To stress or not to stress? Exercise pulmonary haemodynamic testing in systemic sclerosis

European Respiratory Journal

Volumn 48, Issue 6, 2016, Pages 1549-1552

  Lau, Edmund M T ^a   Thakkar, Vivek ^b,c   Humbert, Marc ^d,e,f   Herve, Philippe ^e  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e BICÊTRE HOSPITAL   (France)

^f CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2;

EXERCISE INTENSITY; EXERCISE TEST; GENE MUTATION; HEART OUTPUT; HUMAN; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG HEMODYNAMICS; LUNG RESISTANCE; LUNG WEDGE PRESSURE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; REVIEW; STRESS; SURVIVAL TIME; SYSTEMIC SCLEROSIS; EXERCISE; HEMODYNAMICS;

EXERCISE; EXERCISE TEST; HEMODYNAMICS; HUMANS; SCLERODERMA, SYSTEMIC;

EID: 85006116994     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01809-2016     Document Type: Review

References (30)

1. Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809-1815.
2. Avouac J, Airo P, Meune C, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010; 37: 2290-2298.
3. Launay D, Sitbon O, Hachulla E, et al. Survival in systemic sclerosis-Associated pulmonary arterial hypertension in the modern management era. Ann Rheum Dis 2013; 72: 1940-1946.
4. Condliffe R, Kiely DG, Peacock AJ, et al. Connective tissue disease-Associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009; 179: 151-157.
5. Lau EM, Humbert M, Celermajer DS. Early detection of pulmonary arterial hypertension. Nat Rev Cardiol 2015; 12: 143-155.
6. Humbert M, Gerry Coghlan J, Khanna D. Early detection and management of pulmonary arterial hypertension. Eur Respir Rev 2012; 21: 306-312.
7. Humbert M, Yaici A, de Groote P, et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-Term survival. Arthritis Rheum 2011; 63: 3522-3530.
8. Coghlan JG, Denton CP, Grünig E, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: The DETECT study. Ann Rheum Dis 2014; 73: 1340-1349.
9. Thakkar V, Nikpour M, Stevens WM, et al. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension. Intern Med J 2015; 45: 248-254.
10. Coghlan JG, Bogaard HJ. Exercise pulmonary haemodynamics: A test in search of purpose. Eur Respir J 2016; 47: 1315-1317.
11. Naeije R, Vonk Noordegraaf A, Kovacs G. Exercise-induced pulmonary hypertension: At last! Eur Respir J 2015; 46: 583-586.
12. Naeije R. In defence of exercise stress tests for the diagnosis of pulmonary hypertension. Heart 2011; 97: 94-95.
13. Rubin LJ. Cor pulmonale revisited. J Am Coll Cardiol 2013; 62: 1112-1113.
14. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2015; 46: 903-975.
15. Tolle JJ, Waxman AB, Van Horn TL, et al. Exercise-induced pulmonary arterial hypertension. Circulation 2008; 118: 2183-2189.
16. Lau EM, Chemla D, Whyte K, et al. Does exercise pulmonary hypertension exist? Curr Opin Pulm Med 2016; 22: 400-407.
17. Kovacs G, Maier R, Aberer E, et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med 2009; 180: 881-886.
18. Oliveira RK, Waxman AB, Agarwal M, et al. Pulmonary haemodynamics during recovery from maximum incremental cycling exercise. Eur Respir J 2016; 48: 158-167.
19. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: Suppl., S55-S66.
20. Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: A systematic review. Eur Respir J 2009; 34: 888-894.
21. Kovacs G, Avian A, Olschewski H. Proposed new definition of exercise pulmonary hypertension decreases false-positive cases. Eur Respir J 2016; 47: 1270-1273.
22. Herve P, Lau EM, Sitbon O, et al. Criteria for diagnosis of exercise pulmonary hypertension. Eur Respir J 2015; 46: 728-737.
23. Naeije R, Vanderpool R, Dhakal BP, et al. Exercise-induced pulmonary hypertension: physiological basis and methodological concerns. Am J Respir Crit Care Med 2013; 187: 576-583.
24. Lau EM, Godinas L, Sitbon O, et al. Resting pulmonary artery pressure of 21-24 mmHg predicts abnormal exercise haemodynamics. Eur Respir J 2016; 47: 1436-1444.
25. Stamm A, Saxer S, Lichtblau M, et al. Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis. Eur Respir J 2016; 48: 1658-1667.
26. Godinas L, Lau EM, Chemla D, et al. Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure. Eur Respir J 2016; 48: 254-257.
27. Saggar R, Khanna D, Furst DE, et al. Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum 2010; 62: 3741-3750.
28. Girerd B, Montani D, Jaïs X, et al. Genetic counselling in a national referral centre for pulmonary hypertension. Eur Respir J 2016; 47: 541-552.
29. Saggar R, Khanna D, Shapiro S, et al. Brief report: Effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: A prospective single-center, open-label pilot study. Arthritis Rheum 2012; 64: 4072-4077.
30. Kovacs G, Maier R, Aberer E, et al. Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure. Arthritis Rheum 2012; 64: 1257-1262.